Allosteric modulation of Class C GPCRs: a novel approach for the treatment of CNS disorders
- 2 November 2012
- journal article
- review article
- Published by Elsevier in Drug Discovery Today: Technologies
- Vol. 10 (2) , e269-e276
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu3) NAM probe (ML289) derived from a closely related mGlu5 PAMBioorganic & Medicinal Chemistry Letters, 2012
- Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: Unexpected ‘molecular switch’ from a closely related mGlu4 positive allosteric modulatorBioorganic & Medicinal Chemistry Letters, 2011
- Opposing roles of mGluR8 in measures of anxiety involving non-social and social challengesBehavioural Brain Research, 2011
- Progress toward Positive Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5 (mGlu5)ACS Chemical Neuroscience, 2011
- Recent Progress on the Identification of Metabotropic Glutamate 4 Receptor Ligands and Their Potential Utility as CNS TherapeuticsACS Chemical Neuroscience, 2011
- Recent Advances in the Design and Development of Novel Negative Allosteric Modulators of mGlu5ACS Chemical Neuroscience, 2011
- Recent Progress in the Synthesis and Characterization of Group II Metabotropic Glutamate Receptor Allosteric ModulatorsACS Chemical Neuroscience, 2011
- Recent Advances in the Medicinal Chemistry of the Metabotropic Glutamate Receptor 1 (mGlu1)ACS Chemical Neuroscience, 2011
- Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophreniaTrends in Pharmacological Sciences, 2009
- Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: Unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffoldBioorganic & Medicinal Chemistry Letters, 2008